Alkaline phosphatase engineered B cell therapy(Be Biopharma)

N/A

Report date: 2024/05/27 10:16:41

Base Information

Drug NameAlkaline phosphatase engineered B cell therapy(Be Biopharma)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionAlkaline phosphatase, tissue-nonspecific isozyme replacements
TargetsAlkaline phosphatase, tissue-nonspecific isozyme
Therapy Area/IndicationsRickets, Hypophosphatemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBe Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesBe Biopharma Inc
Inactive CompaniesN/A
Active IndicationsRickets, Hypophosphatemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A